A Randomized Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids (ACS) on Neonatal Outcome

PHASE4CompletedINTERVENTIONAL
Enrollment

437

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Preterm Delivery
Interventions
DRUG

Betamethasone or Dexamethasone (2nd course of ACS)

Course of Betamethasone or Dexamethasone

DRUG

Placebo

Course of Placebo (NS)

Trial Locations (22)

37403

Erlanger Medical Center, Chattanooga

37920

University of Tennessee Medical Center, Knoxville

50314

Mercy Medical Center, Des Moines

64111

Saint Luke's Hospital, Kansas City, Kansas City

65804

Saint John's Regional Health Center, Springfield

80110

Swedish Medical Center, Denver

80124

Skyridge Medical Center, Lonetree

80218

Presbyterian/St Luke's Hospital, Denver

80220

Rose Medical Center, Denver

84132

University of Utah Health Sciences Center, Salt Lake City

85006

Banner Good Sammaritan Hospital, Phoenix

85202

Desert Good Samaritan Hospital, Mesa

85712

Tucson Medical Center, Tucson

89102

University Med. Ctr. of Southern Nevada, Las Vegas

89109

Sunrise Medical Center, Las Vegas

92653

Saddleback Memorial Medical Center, Laguna Hills

92868

University of Sourthern California-Irvine Medical Center, Orange

95124

Good Samaritan Hospital, San Jose

98034

Evergreen Hospital, Kirkland

90801-1428

Long Beach Memorial Medical Center, Long Beach

02111

Tufts-New England Medical Center, Boston

98122-4307

Swedish Medical Center, Seattle

Sponsors
All Listed Sponsors
lead

Obstetrix Medical Group

INDUSTRY

NCT00201643 - A Randomized Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids (ACS) on Neonatal Outcome | Biotech Hunter | Biotech Hunter